BridgeBio to Present New Infigratinib Data in Achondroplasia
PALO ALTO, Calif., September 2, 2026 BridgeBio Pharma, Inc. announced plans to present new clinical data on the impact...
genomic medicine
Advertisement
uniQure Submits BLA for AMT-130 in Huntington’s Disease
LEXINGTON, Mass. and AMSTERDAM, September 2, 2026 uniQure N.V. announced the submission of a Biologics License Application (BLA) to...
SOPHiA GENETICS Partners with AstraZeneca on CDx
Boston, Massachusetts & Rolle, Switzerland, August 4, 2026 SOPHiA GENETICS has entered into a global multi-year collaboration with AstraZeneca...
Endeavor Health Unveils Advanced Genetic Test for Heart Disease
EVANSTON, Ill., June 2, 2026 Researchers at Endeavor Health have developed a groundbreaking genetic screening tool designed to provide...
Azalea Therapeutics Unveils First-Ever In Vivo TRAC-CAR T Cell Engineering Breakthrough at ASGCT 2026
BERKELEY, California, United States – May 8, 2026 Azalea Therapeutics announced groundbreaking late-breaking data at the upcoming American Society...
Advertisement
